Dexcom (NSDQ:DXCM) said last week that it won Health Canada approval for its G6 continuous glucose monitoring system for people with diabetes ages two and up.
The company plans to kick off the G6 commercial launch later this year.
Get the full story at our sister site, Drug Delivery Business News.